V. A. John

869 total citations
34 papers, 716 citations indexed

About

V. A. John is a scholar working on Analytical Chemistry, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, V. A. John has authored 34 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Analytical Chemistry, 10 papers in Pharmacology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in V. A. John's work include Analytical Methods in Pharmaceuticals (15 papers), Inflammatory mediators and NSAID effects (6 papers) and Blood Pressure and Hypertension Studies (3 papers). V. A. John is often cited by papers focused on Analytical Methods in Pharmaceuticals (15 papers), Inflammatory mediators and NSAID effects (6 papers) and Blood Pressure and Hypertension Studies (3 papers). V. A. John collaborates with scholars based in Switzerland, United States and United Kingdom. V. A. John's co-authors include Bret Berner, Keith K. H. Chan, P D Fowler, M F Shadforth, Parviz Mojaverian, M. J. Kendall, William R. Good, CP Quarterman, Peter G. Welling and M. J. Kendall and has published in prestigious journals such as Journal of Controlled Release, The American Journal of Cardiology and European Journal of Biochemistry.

In The Last Decade

V. A. John

34 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. A. John Switzerland	17	182	158	115	89	88	34	716
DG Waller United Kingdom	17	61 0.3×	137 0.9×	77 0.7×	79 0.9×	78 0.9×	28	920
Anthony R. DiSanto United States	15	86 0.5×	135 0.9×	67 0.6×	73 0.8×	39 0.4×	32	596
A. Gérardin Switzerland	13	107 0.6×	153 1.0×	79 0.7×	54 0.6×	24 0.3×	25	630
Marleen Depré Belgium	16	145 0.8×	401 2.5×	29 0.3×	131 1.5×	38 0.4×	43	1.2k
A Nomura Japan	13	61 0.3×	65 0.4×	76 0.7×	122 1.4×	30 0.3×	53	542
Willi Cawello Germany	23	143 0.8×	232 1.5×	39 0.3×	138 1.6×	74 0.8×	75	1.4k
T.N. Calvey United Kingdom	15	61 0.3×	136 0.9×	61 0.5×	124 1.4×	11 0.1×	63	673
R. G. Cooper United Kingdom	8	26 0.1×	141 0.9×	124 1.1×	124 1.4×	26 0.3×	10	744
Emil R. Smith United States	16	19 0.1×	133 0.8×	41 0.4×	211 2.4×	66 0.8×	45	840
Silke Appel‐Dingemanse Switzerland	17	92 0.5×	253 1.6×	29 0.3×	66 0.7×	21 0.2×	30	990

Countries citing papers authored by V. A. John

Since Specialization

Citations

This map shows the geographic impact of V. A. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. A. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. A. John more than expected).

Fields of papers citing papers by V. A. John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. A. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. A. John. The network helps show where V. A. John may publish in the future.

Co-authorship network of co-authors of V. A. John

This figure shows the co-authorship network connecting the top 25 collaborators of V. A. John. A scholar is included among the top collaborators of V. A. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. A. John. V. A. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Notelovitz, Morris, V. A. John, & William R. Good. (2002). Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in healthy, postmenopausal women. Menopause The Journal of The North American Menopause Society. 9(5). 343–353. 30 indexed citations

Good, William R., V. A. John, Maria E. Ramirez, & JAMES HIGGINS. (1999). Comparison of Alora® estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Climacteric. 2(1). 29–36. 17 indexed citations

Good, William R., V. A. John, Maria E. Ramirez, & JAMES HIGGINS. (1996). Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora™) versus placebo in postmenopausal women experiencing menopausal symptoms. Clinical Therapeutics. 18(6). 1093–1105. 19 indexed citations

Cheung, Wing K., et al.. (1995). Intra- and Inter-Subject Variabilities of CGP 33101 after Replicate Single Oral Doses of Two 200-mg Tablets and 400-mg Suspension. Pharmaceutical Research. 12(12). 1878–1882. 19 indexed citations

Morgan, John, et al.. (1994). APPLICATION OF A STABLE ISOTOPE TECHNIQUE FOR THE BIOEQUIVALENCY STUDY OF TWO TRANSDERMAL NITROGLYCERIN SYSTEMS. American Journal of Therapeutics. 1(1). 15–21. 3 indexed citations

Harrigan, Edmund P., et al.. (1994). PHARMACOKINETICS OF A NEW ANTICONVULSANT(CGP 33101) IN EPILEPTIC MALE PATIENTS AND HEALTHY MALE SUBJECTS AFTER SINGLE ASCENDING ORAL DOSES OF 400–1200 mg. American Journal of Therapeutics. 1(3). 215–220. 11 indexed citations

Sioufi, A., et al.. (1994). The absence of a pharmacokinetic interaction between aspirin and the angiotensin‐converting enzyme inhibitor benazepril in healthy volunteers. Biopharmaceutics & Drug Disposition. 15(6). 451–461. 3 indexed citations

Berner, Bret & V. A. John. (1994). Pharmacokinetic Characterisation of Transdermal Delivery Systems. Clinical Pharmacokinetics. 26(2). 121–134. 106 indexed citations

Chan, Keith K. H., Akshay Buch, Robert Glazer, V. A. John, & William H. Barr. (1994). Site-Differential Gastrointestinal Absorption of Benazepril Hydrochloride in Healthy Volunteers. Pharmaceutical Research. 11(3). 432–437. 23 indexed citations

10.

Cheung, Wing K., Lane J. Brunner, Steve Schoenfeld, et al.. (1994). PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN CANCER PATIENTS AFTER A SINGLE INTRAVENOUS INFUSION OF 30-, 60− OR 90-mg DOSE OVER 4 OR 24 HOURS. American Journal of Therapeutics. 1(3). 228–235. 6 indexed citations

11.

Cipriano, Alessandra, et al.. (1994). Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects. European Journal of Clinical Pharmacology. 47(3). 285–289. 16 indexed citations

12.

Cassidy, James, Bret Berner, Keith K. H. Chan, et al.. (1993). Human Transbuccal Absorption of Diclofenac Sodium from a Prototype Hydrogel Delivery Device. Pharmaceutical Research. 10(1). 126–129. 22 indexed citations

13.

Morgan, John, David M. Capuzzi, William R. Good, et al.. (1993). Hypoglycemic and Insulin Response to a Continuous Intravenous Infusion of CGP‐35126 Recombinant Human Insulin‐Like Growth Factor‐I (rhIGF‐I) in Healthy Males. The Journal of Clinical Pharmacology. 33(4). 366–372. 2 indexed citations

14.

Chan, Keith K. H., et al.. (1991). Pharmacokinetics of Multiple Daily Transdermal Doses of Nicotine in Healthy Smokers. Pharmaceutical Research. 8(3). 385–388. 20 indexed citations

15.

John, V. A.. (1990). A structured approach to the development of a controlledrelease drug delivery system for a β-adrenoceptor blocking drug. Journal of Controlled Release. 11(1-3). 307–314. 6 indexed citations

16.

Chan, Keith K. H., et al.. (1990). Pharmacokinetics of a single transdermal dose of nicotine in healthy smokers. Journal of Controlled Release. 14(2). 145–151. 9 indexed citations

17.

Kochak, Gregory M., et al.. (1989). Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.. Pharmaceutical Research. 6(4). 328–331. 10 indexed citations

18.

Mojaverian, Parviz, et al.. (1989). Gastrointestinal Transit of a Solid Indigestible Capsule as Measured by Radiotelemetry and Dual Gamma Scintigraphy. Pharmaceutical Research. 6(8). 719–724. 62 indexed citations

19.

Kendall, M. J., V. A. John, CP Quarterman, & Peter G. Welling. (1980). A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metoprolol. European Journal of Clinical Pharmacology. 17(2). 87–92. 61 indexed citations

20.

Aylward, Mansel, P D Fowler, V. A. John, J. Maddock, & J Seldrup. (1979). The influence of diclofenac sodium (Voltarol) on free, protein-bound and total plasma L-tryptophan in adult healthy male subjects.. ORCA Online Research @Cardiff (Cardiff University). Suppl 2. 47–59. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact